Shares of RTW Biotech Opportunities (LON:RTW – Get Free Report) rose 1.3% on Tuesday . The stock traded as high as GBX 1.55 ($0.02) and last traded at GBX 1.55 ($0.02). Approximately 761,386 shares traded hands during mid-day trading, an increase of 56% from the average daily volume of 488,407 shares. The stock had previously closed at GBX 1.53 ($0.02).
RTW Biotech Opportunities Stock Up 1.3 %
The firm’s 50 day moving average price is GBX 1.55 and its two-hundred day moving average price is GBX 1.46. The firm has a market capitalization of £5.20 million, a PE ratio of 4.31 and a beta of 0.60.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Read More
- Five stocks we like better than RTW Biotech Opportunities
- Canada Bond Market Holiday: How to Invest and Trade
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Technology Stocks Explained: Here’s What to Know About Tech
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
